PeptidePedia The community reference

Talk:Placebo-adjusted effect

Discussion page·2 threads·no archives

This article is within the scope of the clinical evidence working group.

This is the discussion page for the article Placebo-adjusted effect. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Placebo response is only one componentResolved

Separating regression to the mean, the trial's own intervention, observation effects and the placebo response proper is worth doing. They are routinely lumped together as "the placebo effect". — EndpointEnid (talk) 09:40, 9 March 2026 (UTC)

And noting that the expectation component is small for objective endpoints prevents the opposite overcorrection. ✓ Done — ForestPlotFinn (talk) 13:15, 9 March 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Blinding failure

Agents with marked gastrointestinal effects are imperfectly blinded in practice. It is unquantifiable but it should be named. — PreregPriya (talk) 10:25, 1 June 2026 (UTC)

Named, and flagged as a general limitation rather than a defect of any one trial. — SurrogateSunday (talk) 14:00, 1 June 2026 (UTC)

This page was last edited on 1 June 2026, by SurrogateSunday. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).